LEVODOPA DERIVATIVE AND USE THEREOF
摘要:
[Object]
To provide a drug that can mitigate shortcomings, such as low retention in blood, associated with L-DOPA in treating Parkinson's disease.
[Solution]
Incorporation of L-DOPA into a carrier in a form of a block copolymer (PEG-b-poly(3,4-hydroxy-protected L-DOPA)) significantly improves the retention of the agent in the blood.
信息查询
0/0